会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Azacyclooctane and heptane derivatives, their preparation and use in therapy
    • 氮杂环辛烷和庚烷衍生物,其制备和用于治疗
    • US06680314B2
    • 2004-01-20
    • US10134498
    • 2002-04-30
    • Dan PetersGunnar M. OlsenSimon F. NielsenElsebet O. Nielsen
    • Dan PetersGunnar M. OlsenSimon F. NielsenElsebet O. Nielsen
    • A61K3155
    • C07D401/04C07D223/06C07D225/02
    • Compounds of formula (1) or (2), enantiomers thereof, mixtures thereof, and pharmaceutically acceptable salts thereof: wherein: n is 0, or 1; R is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl; and R1 is aryl optionally substituted with alkyl, cycloalkyl, cycloalkylalkyl alkenyl, alkynyl, alkoxy, cycloalkoxy, thioalkoxy, thiocycloalkoxy, methylenedioxy, aryloxy, halogen, CF3, OCF3, CN, amino, nitro, aryl, or a monocyclic 5 to 6-membered heteroaryl group, or R is a monocyclic 5 to 6-membered heteroaryl group optionally substituted with alkyl, cycloalkyl, cycloalkylalkyl alkenyl, alkynyl, alkoxy, cycloalkoxy, thioalkoxy, thiocycloalkoxy, methylenedioxy, aryloxy, halogen, CF3, OCF3, CN, amino, nitro, aryl, or a monocyclic 5 to 6-membered heteraryl group, or R is a bicyclic heteroaryl group composed of a monocyclic 5 to 6-membered heteroaryl group fused to a benzene ring, optionally substituted with alkyl, cycloalkyl, cycloalkylalkyl alkenyl, alkynyl, alkoxy, cycloalkoxy, thioalkoxy, thiocycloalkoxy, methylenedioxy, aryloxy, halogen, CF3, OCF3, CN, amino, nitro, aryl, or a monocyclic 5 to 6-membered heteroaryl group. The compounds, enantiomers, and salts are useful as ligands for nicotinic ACh receptors.
    • 式(1)或(2)的化合物,其对映异构体,其混合物及其药学上可接受的盐:其中:n为0或1; R是氢,烷基,烯基,炔基,环烷基,环烷基烷基,芳基或芳烷基; 并且R 1为任选被烷基,环烷基,环烷基烷基烯基,炔基,烷氧基,环烷氧基,硫代烷氧基,硫代环烷氧基,亚甲二氧基,芳氧基,卤素,CF 3,OCF 3,CN,氨基,硝基,芳基或单环5至 或者R是任选被烷基,环烷基,环烷基烷基烯基,炔基,烷氧基,环烷氧基,硫代烷氧基,硫代环烷氧基,亚甲二氧基,芳氧基,卤素,CF 3,OCF 3,CN取代的单环5至6元杂芳基, 氨基,硝基,芳基或单环5至6元杂芳基,或R为由与苯环稠合的单环5至6元杂芳基组成的双环杂芳基,任选被烷基,环烷基,环烷基烷基烯基 炔基,烷氧基,环烷氧基,硫代烷氧基,硫代环烷氧基,亚甲二氧基,芳氧基,卤素,CF 3,OCF 3,CN,氨基,硝基,芳基或单环5至6元杂芳基。 化合物,对映体和盐可用作烟碱型ACh受体的配体。
    • 4. 发明授权
    • Azacyclooctane and heptane derivatives, their preparation and use in therapy
    • 氮杂环辛烷和庚烷衍生物,其制备和用于治疗
    • US06420395B1
    • 2002-07-16
    • US09450636
    • 1999-11-29
    • Dan PetersGunnar M. OlsenSimon F. NielsenElsebet O. Nielsen
    • Dan PetersGunnar M. OlsenSimon F. NielsenElsebet O. Nielsen
    • A61K3144
    • C07D401/04C07D223/06C07D225/02
    • The present invention discloses compounds of formula (1) or (2), any of its enantiomers or any mixture thereof, or a pharmaceutically acceptable salt thereof; wherein n is 0, or 1; R is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalky-alkyl, aryl or aralkyl; and R1 is aryl which may be substituted one or more times with substituents selected from the group consisting of alkyl, cycloalkyl, cyloalkylalkyl alkenyl, alkynyl, alkoxy, cycloalkoxy, thioalkoxy, thiocycloalkoxy, methylenedioxy, aryloxy, halogen, CF3, OCF3, CN, amino, nitro, aryl and a monocyclic 5 to 6-membered heteroaryl group a monocyclic 5 to 6-membered heteroaryl group which may be substituted one or more times with substituents selected from the group consisting of alkyl, cycloalkyl, cycloalkylalkyl alkenyl, alkynyl, alkoxy, cycloalkoxy, thioalkoxy, thiocycloalkoxy, methylenedioxy, aryloxy, halogen, CF3, OCF3. CN, amino, nitro, aryl and a monocyclic 5 to 6-membered heteroaryl group, or a bicyclic heteroaryl group composed of a monocyclic 5 to 6-membered heteroaryl group fused to a benzene ring and which may be substituted one or more times with substituents selected from the group consisting of alkyl, cycloalkyl, cycloalkylalkyl alkenyl, alkynyl, alkoxy, cycloalkoxy, thioalkoxy, thiocycloalkoxy, methylenedioxy, aryloxy, halogen, CF3, OCF3, CN, amino, nitro, aryl and a monocyclic 5 to 6-membered heteroaryl group. The compounds of the invention are useful as nicotinic ACh receptor ligands.
    • 本发明公开了式(1)或(2)的化合物,其任何对映体或其任何混合物或其药学上可接受的盐; 其中n为0或1; R是氢,烷基,烯基,炔基,环烷基,环烷基,芳基或芳烷基; 并且R 1是可以被选自烷基,环烷基,环烷基烷基烯基,炔基,烷氧基,环烷氧基,硫代烷氧基,硫代环烷氧基,亚甲二氧基,芳氧基,卤素,CF 3,OCF 3,CN,氨基的取代基取代一次或多次的芳基 ,硝基,芳基和单环5至6元杂芳基,可以被选自烷基,环烷基,环烷基烷基烯基,炔基,烷氧基, 环烷氧基,硫代烷氧基,硫代环烷氧基,亚甲二氧基,芳氧基,卤素,CF 3,OCF 3。 CN,氨基,硝基,芳基和单环5至6元杂芳基,或由与苯环稠合的单环5至6元杂芳基组成的双环杂芳基,其可以被取代基取代一次或多次 选自烷基,环烷基,环烷基烷基烯基,炔基,烷氧基,环烷氧基,硫代烷氧基,硫代环烷氧基,亚甲二氧基,芳氧基,卤素,CF 3,OCF 3,CN,氨基,硝基,芳基和单环5至6元杂芳基 。 本发明的化合物可用作烟碱ACh受体配体。
    • 5. 发明授权
    • 1-substituted-2-(N-pheny
l-N-(phenylmethyl)methanamine)-4,5-dihydro-imidazoles and related
compounds and their use in treating calcium overload in brain cells
    • 1-取代-2-(N-苯基-N-(苯甲基)甲胺)-4,5-二氢咪唑及其相关化合物及其在脑细胞中治疗钙超载中的应用
    • US5296493A
    • 1994-03-22
    • US704469
    • 1991-05-23
    • Peter MoldtElsebet O. Nielsen
    • Peter MoldtElsebet O. Nielsen
    • C07D233/24C07D233/54C07D233/60C07D235/14C07D401/12C07D403/06C07D405/12A61K31/415A61K31/44C07D233/61C07D401/06
    • C07D233/64C07D233/24C07D235/14C07D401/12C07D403/06C07D405/12
    • The present patent application discloses compounds of the formula ##STR1## wherein R.sup.1 is C.sub.1-10 saturated or unsaturated alkyl; or ##STR2## wherein R'" is H or ##STR3## R.sup.2 is phenyl which is unsubstituted or substituted one or more times with halogen, CF.sub.3, C.sub.1-6 -alkoxy, NO.sub.2, CO.sub.2 --C.sub.1-6 -alkyl, methyl; benzyl which may be substituted one or more times with halogen, CF.sub.3, C.sub.1-6 -alkoxy, NO.sub.2, CO.sub.2 --C.sub.1-6 -alkyl, methyl; pyridyl; or cyclohexyl;R.sup.3 phenyl which is unsubstituted or substituted one or more times with halogen, CF.sub.3, C.sub.1-6 -alkoxy, NO.sub.2, CO.sub.2 --C.sub.1-6 -alkyl, methyl; naphthyl which may be substituted one or more times with halogen, CF.sub.3, C.sub.1-6 -alkoxy, NO.sub.2, CO.sub.2 --C.sub.1-6 -alkyl, methyl; pyridyl; C.sub.1-6 unsaturated alkyl; furanyl;R.sup.4 is H, C.sub.1-6 -alkyl, or benzyl; or ##STR4## together form ##STR5## R' and R" are each hydrogen or together form an extra benzo ring; and wherein the dotted line represents an optional extra bond between the two carbon atoms designated .alpha. and .beta.,or a pharmaceutically-acceptable addition salt thereof.The compounds are useful as pharmaceuticals, for example in the treatment of Ca overload in brain cells.
    • 本专利申请公开了式IMA的化合物,其中R 1是C 1-10饱和或不饱和的烷基; 或者其中R“'为H或R 2是未被取代或被卤素,CF 3,C 1-6 - 烷氧基,NO 2,CO 2 -C 1-6 - 烷基,甲基取代或被取代的苯基。 可以被卤素,CF 3,C 1-6 - 烷氧基,NO 2,CO 2 -C 1-6 - 烷基,甲基取代一次或多次的苄基; 吡啶基 或环己基; R 3苯基,其未被取代或被卤素,CF 3,C 1-6 - 烷氧基,NO 2,CO 2 -C 1-6烷基,甲基取代一次或多次; 可以被卤素,CF 3,C 1-6 - 烷氧基,NO 2,CO 2 -C 1-6 - 烷基,甲基取代一次或多次的萘基; 吡啶基 C 1-6不饱和烷基; 呋喃基 R4是H,C1-6烷基或苄基; 或一起形成 R'和R“各自为氢或一起形成额外的苯并环; 并且其中虚线表示指定为α和β的两个碳原子之间的任选的额外键或其药学上可接受的加成盐。 这些化合物可用作药物,例如用于治疗脑细胞中的Ca超载。